Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoNovavax. Last year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks via Yahoo Finance· 7 days agoZacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
Novavax (NASDAQ:NVAX) PT Raised to $18.00
ETF DAILY NEWS· 1 day agoNovavax (NASDAQ:NVAX – Get Free Report) had its target price increased by Bank of America from $12.00 to $18.00 in a research report issued to clients and investors on Friday ...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 3 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 3 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA advises Covid vaccine makers to target new contagious strain for fall shots
NBC Universal via AOL· 3 days agoThe FDA advised drugmakers to update Covid vaccines to target the KP.2 strain, a descendant of the...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 3 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 7 days agoModerna has not said when the combination vaccine might be evaluated by the FDA. Both Pfizer-BioNTech and Novavax are studying combination vaccines ...